Chromogenic detection of telomere lengths in situ aids the identification of precancerous lesions in the prostate

Abstract

AbstractBackgroundTelomeres are terminal chromosomal elements that are essential for the maintenance of genomic integrity. The measurement of telomere content provides useful diagnostic and prognostic information, and fluorescent methods have been developed for this purpose. However, fluorescent‐based tissue assays are cumbersome for investigators to undertake, both in research and clinical settings.MethodsA robust chromogenic in situ hybridization (CISH) approach was developed to visualize and quantify telomere content at single cell resolution in human prostate tissues, both frozen and formalin‐fixed, paraffin‐embedded (FFPE).ResultsThis new assay (telomere chromogenic in situ hybridization [“Telo‐CISH”]) produces permanently stained slides that are viewable with a standard light microscope, thus avoiding the need for specialized equipment and storage. The assay is compatible with standard immunohistochemistry, thereby allowing simultaneous assessment of histomorphology, identification of specific cell types, and assessment of telomere status. In addition, Telo‐CISH eliminates the problem of autofluorescent interference that frequently occurs with fluorescent‐based methods. Using this new assay, we demonstrate successful application of Telo‐CISH to help identify precancerous lesions in the prostate by the presence of markedly short telomeres specifically in the luminal epithelial cells.ConclusionsIn summary, with fewer restrictions on the types of tissues that can be tested, and increased histologic information provided, the advantages presented by this novel chromogenic assay should extend the applicability of tissue‐based telomere length assessment in research and clinical settings.